Argos therapeutics inc. stock
All News for ARGS : - Zacks.com Argos Therapeutics (ARGS) Looks Good: Stock Rises by 5%. by Zacks Equity Research Published on January 06,2017 . Argos Therapeutics, Inc.(ARGS) was a big mover last session, as the company saw its Argos Therapeutics Price | Markets Insider Argos Therapeutics Price: This is the Price-site for the company Argos Therapeutics on Markets Insider Stock Exchanges* Argos Therapeutics Inc Registered Rg Exchange Last Prev. Close Time to Hop in the Argos Therapeutics Inc (NASDAQ:ARGS ... May 10, 2016 · Argos Therapeutics Inc (NASDAQ:ARGS) shares were up 18.12% to $6.91 in Monday’s New York session and an additional 2.17% in after-hours trading to $7.06.Argos Therapeutics Inc (NASDAQ:ARGS) shares hit a high of $7.64 on Monday before sliding lower, offering an opportunity to catch a short-term pullback.Prior to the early Monday rally, share … ARGS: Argos Therapeutics, Inc. (ARGS): Stock Offering News
10-Q: ARGOS THERAPEUTICS INC - MarketWatch
Oct 22, 2019 · Argos Therapeutics, Inc. focuses on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases in North America. The company was founded in 1997 and is based in Durham, North Carolina. View our full ARGS ticker page with ratings, news, and more. 10-Q: ARGOS THERAPEUTICS INC - MarketWatch Nov 19, 2018 · We also recognized $3.2 million in stock-based compensation expense from the acceleration of vesting of stock options and restricted stock held by the terminated employees during the year ended Argos Therapeutics (PK) Stock Quote. ARGSQ - Stock Price ... Argos Therapeutics (PK) stock quote and ARGSQ charts. Latest stock price today and the US's most active stock market forums. Argos Therapeutics (PK) (ARGSQ) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
Get breaking news and analysis on Argos Therapeutics, Inc. (ARGSQ) stock, price quote and chart, trading and investing tools.
Argos Therapeutics Inc - Ordinary Shares (ARGSQ) Pre-Market Stock Quotes - Nasdaq offers pre-market quotes and pre-market activity data for US and global markets.
25 Sep 2019 Argos Therapeutics Inc. (fka ARGSQ) Message Board. Argos Therapeutics, Inc. , a biopharmaceutical company, focuses on the #1965, ARGS~~bad news,,* Argos Therapeutics Says Trading In Common Stock · m1999
ARGS / Argos Therapeutics, Inc. - Institutional Ownership ... ARGS / Argos Therapeutics, Inc. / ForArgos B.V. - SC 13D/A Activist Investment. 02-16 sec.gov - 1 SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2)* ARGOS THERAPEUTICS INC. Korean bio firms acquire US biotech firm Argos Therapeutics Korean bio companies SCM Life Science and Genexine have teamed up to acquire US-based Argos Therapeutics, the companies announced Wednesday. Argos Therapeutics, a cancer vaccine developer, is to
Apr 24, 2018 · april 24 (reuters) - argos therapeutics inc: * argos therapeutics - on april 23, nasdaq hearing panel determined to delist co’s shares from nasdaq capital market
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates … - ARGS - Stock Price Today - Zacks View %COMPANY_NAME% ARGS investment & stock information. Get the latest %COMPANY_NAME% ARGS detailed stock quotes, stock data, … Argos Therapeutics Inc Stock Candlestick Chart (ARGSQ ... Dozens of bullish and bearish live candlestick chart patterns for the Argos Therapeutics Inc stock and use them to predict future market behavior.
Argos Therapeutics, Inc., a biotechnology company, engages in developing immunotherapy treatments for cancer, infectious and autoimmune diseases, and transplantation rejection. The company has clinical trial programs in cancer and human immunodeficiency virus.